RxDoctor Payments Data

Darin Fincher, PA

Surgical · Springfield, MONPI 1205898459

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 22 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Atricure, Inc. at 27.4% of the total. Reporting peaked in 2021 at $714 and has fallen 54.4% since, to $325 in 2025.

$1,434in general payments, 2019–2025

Across 22 payments — averaging $65.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Atricure, Inc.$393
  • Johnson & Johnson$255
  • Getinge USA Sales, LLC$186
  • Davol Inc.$146
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$105
  • Bioventus LLC$94
  • plus $256 from 4 others

What the payments were for

  • Food & beverage$1,434100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Atricure, Inc.4$393
Johnson & Johnson2$255
Getinge USA Sales, LLC5$186
Davol Inc.1$146
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)3$105
Bioventus LLC1$94
Radius Health, Inc.1$87
Terumo Cardiovascular Systems Corporation1$83
Novartis3$43
AstraZeneca1$42

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,434 in reported general payments places this provider in the 80th percentile of 118 surgical providers in Missouri.

See all surgical providers in Missouri

Medicare billing

Part B allowed, 2024
$23,709
Medicare patients
154
Services billed
395

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cyclobenzaprine Hcl16$78

Paid to pharmacies, not to this prescriber.

Other surgical in Springfield

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →